Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Torin1

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

InvivoGen

Drug class:

mTOR inhibitor, mTORC2 inhibitor

Related drugs:

‹

encapsulated rapamycin (0)

inhibitors of the PI3K/AKT/mTOR pathway (0)

albumin-bound (0)

everolimus (138)

temsirolimus (37)

PF-05212384 (31)

GSK2126458 (17)

PF-04691502 (6)

niclosamide (1)

rapamycin topical (0)

ridaforolimus (0)

encapsulated rapamycin (0)

inhibitors of the PI3K/AKT/mTOR pathway (0)

albumin-bound (0)

›

TMB-L	Pancreatic Ductal Adenocarcinoma	TMB-L	Pancreatic Ductal Adenocarcinoma	trametinib + Torin1 Sensitive: D – Preclinical trametinib + Torin1 Sensitive : D	trametinib + Torin1 Sensitive: D – Preclinical trametinib + Torin1 Sensitive : D
MTOR F2108L	Thyroid Gland Carcinoma	MTOR F2108L	Thyroid Gland Carcinoma	Torin1 Sensitive: D – Preclinical Torin1 Sensitive : D	Torin1 Sensitive: D – Preclinical Torin1 Sensitive : D